1. Home
  2. ALLO vs PAMT Comparison

ALLO vs PAMT Comparison

Compare ALLO & PAMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$1.80

Market Cap

252.9M

Sector

Health Care

ML Signal

HOLD

Logo PAMT CORP

PAMT

PAMT CORP

HOLD

Current Price

$11.81

Market Cap

268.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLO
PAMT
Founded
2017
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Trucking Freight/Courier Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
252.9M
268.9M
IPO Year
2018
1985

Fundamental Metrics

Financial Performance
Metric
ALLO
PAMT
Price
$1.80
$11.81
Analyst Decision
Strong Buy
Hold
Analyst Count
12
1
Target Price
$8.27
$13.00
AVG Volume (30 Days)
6.3M
24.5K
Earning Date
03-12-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$598,056,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$12.19
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.86
$8.90
52 Week High
$3.78
$17.29

Technical Indicators

Market Signals
Indicator
ALLO
PAMT
Relative Strength Index (RSI) 58.49 50.04
Support Level $1.56 $11.18
Resistance Level $1.84 $13.21
Average True Range (ATR) 0.16 0.80
MACD -0.01 0.00
Stochastic Oscillator 67.96 55.56

Price Performance

Historical Comparison
ALLO
PAMT

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

About PAMT PAMT CORP

PAMT Corp is a holding company that is engaged in providing truckload dry van carriers transporting general commodities throughout the continental United States, as well as the Canadian provinces of Ontario and Quebec. It has one reportable segment being motor carrier.

Share on Social Networks: